Charles Evan Ballantyne, Chief Financial Officer at Synthetic Biologics, Inc. (SYN), bought 10,000 shares at $1.35 ($14K) on 2014-05-22, disclosed to the SEC on 2014-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CLDA | BUY | 2007-12-14 | $4K | — | Filing → |
| CLDA | BUY | 2007-09-06 | $40K | — | Filing → |
| CLDA | BUY | 2006-12-11 | $10K | — | Filing → |